Found: 5
Select item for more details and to access through your institution.
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1191217
- By:
- Publication type:
- Article
Chromatin complex dependencies reveal targeting opportunities in leukemia.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36150-7
- By:
- Publication type:
- Article
Extended-representation bisulfite sequencing of gene regulatory elements in multiplexed samples and single cells.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 9, p. 1086, doi. 10.1038/s41587-021-00910-x
- By:
- Publication type:
- Article
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00258-0
- By:
- Publication type:
- Article
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1481, doi. 10.1093/neuonc/nox052
- By:
- Publication type:
- Article